Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAPEPLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFPI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM69A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GZMA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAUR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEF2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on